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 Motor neurone disease (MND), also referred to as amyotrophic lateral sclerosis (ALS) 
and Lou Gehrig disease in the US, is a life-limiting neurodegenerative condition. The 
condition progressively destroys the motor neurons in the brain and spinal cord and alters an 
individual’s ability to control voluntarily their muscle movements, leading to paralysis, 
swallowing difficulties, respiratory failure and, ultimately, death (King, Mulligan & 
Stansfield, 2014). The effects of MND are not limited to motor functions; behaviour 
difficulties, cognitive impairment (McCluskey et al., 2009; Strong et al., 1999), emotional 
difficulties (depression, anxiety and anger) and involuntary changes in mood (Orrell, 2016) 
are also common. With a prevalence rate for North America and Europe of around two per 
100,000 of the population (Worms, 2001),  median survival rates following symptom onset 
are generally only two to four years, with only 10%-20% of individuals surviving past 10 
years (Chiò et al., 2009). 
 Current interventions for individuals with MND mainly focus upon the physical 
aspects of the condition, to maintain physical and biological functioning and quality of life 
for as long as possible (Andersen et al., 2012).  However, a recent mixed-method review on 
the supportive needs of this group (Oh & Kim, 2017) reported that of the 37 studies included, 
only around half discussed psychosocial needs, concluding a significant need for more 
psychological, social and emotional support, alongside physical and practical assistance. The 
authors also proposed that the psychological impact of receiving, adjusting and coping with 
this diagnosis should be considered equally with the physical impact of the condition.  
 Individuals with a diagnosis of MND are reported to experience heightened 
psychological distress and decreased well-being (Hogg, Goldstein & Leigh, 1994; Lou, 
Reeves, Benice & Sexton, 2003; Montgomery & Erikson, 1987; Tedman, Young & Williams, 
1997; Vignola et al., 2008).  Although several factors undoubtedly contribute to this (e.g., 




biological, social, psychological and ‘spiritual’ suffering: Ganzini, Johnston & Hoffman, 
1999; social withdrawal: Rigby et al., 1999; and physical impairment: Hunter, Robinson & 
Neilson, 1993; Hogg et al., 1994), recent research in other physical health conditions has 
suggested that stigma may be an important variable to consider. This has been identified as 
important in health conditions with perceivable physical effects such as epilepsy (Baker, 
Eccles & Caswell, 2018), Parkinson’s disease (Simpson, MacMillan & Reeve, 2012) and 
multiple sclerosis (Broersma, Oeseburg, Dijkstra & Wynia, 2018).    
The term stigma was originally defined by Goffman (1963) as “an undesired 
differentness” (p. 5) and this has since been developed to include two concepts of stigma: felt 
and enacted (Scambler & Hopkins, 1986).  ‘Felt stigma’ refers to a feeling of shame about 
being different and feeling that discrimination for this difference will occur, whereas ‘enacted 
stigma’ refers to actual experience of this discrimination. Link and Phelan (2001) further 
developed the concept and described stigma as a set of components which include labelling, 
stereotyping, separation, status loss, and discrimination. Therefore, the term stigma can 
encompass a range of negative actions and associations that can be attributed to an individual 
based on their perceived differentness.  In relation to MND, only one study has quantitatively 
assessed stigma (van der Beek, Bos, Middel & Wynia, 2013). Although the authors found 
that stigma was a major predictor of poorer quality of life, with ‘felt stigma’ a stronger 
predictor than ‘enacted stigma’,  the study’s outcome measure was quality of life, rather than 
psychological distress in particular, and individuals diagnosed with MND only made up 9% 
of the total number of participants.  Furthermore, no research has been conducted to assess 
the role that felt stigma plays in mediating the relationship between enacted stigma and 
psychological distress, as theorised in the self stigma model proposed by Corrigan and 
colleagues (Corrigan & Watson, 2002; Corrigan, Watson & Barr, 2006).    




Another variable which has been less studied in motor neurone disease as opposed to 
other neurodegenerative conditions is social support.  Research has identified social support 
as a significant predictor of psychological distress (conceptualised as depression and quality 
of life; Matuz, Birbaumer, Hautzinger & Kübler, 2010).  Furthermore, longitudinal research 
has also identified social support as a significant predictor of depression and quality of life 
(Matuz, Birbaumer, Hautzinger, & Kübler, 2015) and depression and anxiety (Goldstein, 
Atkins, Landau, Brown and Leigh, 2006).  Despite research identifying social support as a 
significant predictor of psychological distress for individuals with MND, no research has 
been conducted, to the best of the authors’ knowledge, to assess whether social support acts 
as a moderator between MND related stress and psychological distress.  This moderating 
effect of social support would suggest that social support could act as a ‘buffer’ on the 
relationship between MND related stress and psychological distress, as proposed in the stress 
buffering model (Barrera, 1986; Cohen & Wills, 1985; Cutrona & Russell, 1990; Thoits, 
1986).   
Consequently, this study aims to investigate the mechanisms through which perceived 
stigma and social support influence the relationship between MND related stress and 
psychological distress for people with MND.  The research aim was to investigate whether 
increased levels of perceived stigma and lower levels of social support influenced the 
relationship between MND related stress and psychological distress.  It was hypothesised that 
both enacted and felt stigma would be significant predictors of psychological distress in 
individuals with MND, and that felt stigma would significantly mediate the relationship 
between enacted stigma and psychological distress (depression, anxiety and stress).  
Furthermore, it was hypothesised that social support would significantly moderate the 
relationship between MND related stress and psychological distress.  
Method 





 A quantitative cross-sectional survey design was used to investigate: a) whether felt 
stigma mediated the relationship between enacted stigma and psychological distress; and b) if 
social support had a moderating effect on the relationship between MND related stress 
(conceptualised as scores on a measure of both physical functioning and enacted stigma) and 
psychological distress (depression, anxiety and stress) in individuals with a diagnosis of 
MND.   Both the mediation and moderation analyses were conducted using Hayes’ 
PROCESS Tool (Hayes, 2018). 
Participants 
Individuals aged 18 years or over who had a diagnosis of MND/ ALS/ Lou Gehrig 
disease and who could complete an online survey written in English (either alone or with 
assistance from another person) were eligible to take part.  An opportunistic sampling method 
was employed as participants volunteered to participate following advertisement of the study 
details online, using social media and through international organisations.  If a participant 
wished to take part in the study, then they accessed the study link provided in the study advert 
and were given the opportunity to read and download the participant information sheet.  
Eligibility for the study was based on self-report and was recorded through a demographic 
questionnaire at the beginning of the survey.   
The literature was consulted to determine the required sample size to detect the 
mediated effect and based on using an indirect effect method of mediation with bias-
corrected bootstrapping and medium effect size in both arms (a=.39 and b=.39), 71 
participants were needed for 80% power (Fritz & MacKinnon, 2007).  For moderation 
analyses, effect sizes are typically small (Aguinis, Beaty, Boik, & Pierce, 2005), with 
suggested sizes for f2 of 0.005, 0.01, and 0.025 for small, medium, and large effects, 




respectively (Kenny, 2018). A large effect size would need 316 participants to detect an 
effect (G*power; Faule, Erdfelder, Buchner & Lang, 2009).  A total of 77 participants were 
recruited; 34 women and 43 men (M age = 59.14).  Of the 94 participants who opened the 
survey, 84 completed the demographic data, with only 80 of these continuing to complete the 
outcome measures.  Of these, only 78 completed all the measures (two participants did not 
complete the physical functioning measure and their data were withdrawn).  A further 
participant’s data were withdrawn due to not meeting the inclusion criteria of being 
completed by an individual with a diagnosis of MND.  See Table 1 for participants’ self-
reported demographic characteristics.   
 
    --------------------------------------- 
Insert Table 1 here please 
    --------------------------------------- 
 
Procedure 
Ethical approval was gained from the first author’s host academic institution after 
input from service users. Recruitment took place online from a variety of sources, mainly 
through international organisations supporting people with MND.  This was achieved by 
sharing the study advert and link on social media (Facebook and Twitter) pages by the Motor 
Neurone Disease Association (MNDA) Australia, MNDA UK, MNDA New Zealand, 
MNDA Scotland, ALS Association Canada, ALS Society Quebec, Minds and Movement, 
and the first author’s own contacts.  An online survey was constructed using Qualtrics 
software which was used to collect the data.  Prior to completing the survey each participant 
accessed the participant information sheet and then consented to take part. Following 
completion of the questionnaires, a debrief sheet was available which also provided the 




contact details of organisations who could provide support if participation caused any 
distress.   
 Measures   
 To control for potential confounders, measures were included to assess demographic 
variables (age and gender), along with the three variables of interest (physical functioning, 
social support and stigma).  One measure was used to assess the three outcomes of 
psychological distress (measuring depression, anxiety and stress).   To situate the sample 
additional variables were collected including nationality, relationship status, time since 
symptom onset and time since diagnosis. 
Physical Functioning 
The Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale 
Revised (SA-ALSFRS-R; Cedarbaum et al., 1999; Montes et al., 2006) includes 12 questions 
which assess the domains of motor function, bulbar symptoms and breathing ability in 
individuals with MND.  Individual items are rated on a scale of 0 to 4 with a total score range 
of 0 to 48; higher scores indicate higher levels of physical functioning.  Although there is no 
current evidence regarding the reliability and validity of the SA-ALSFRS-R, there is 
evidence regarding the clinician administered ALSFRS-R.  This has been shown to be a 
reliable and valid measure by the authors during development (Cedarbaum et al., 1999).  
Montes et al. (2006) compared the use of the SA-ALSFRS-R to the clinician administered 
ALSFRS-R and reported an intraclass correlation coefficient score of r = 0.93, implying that 
the self-administered version is as reliable as the clinician administered version.  This 
measure was chosen as it is aimed specifically at individuals with a diagnosis of MND to 
assess their physical functioning and symptom severity.  The use of the ALSFRS-R 
instrument online compared to on-site face-to-face assessment was assessed by Maier et al. 




(2012) and their results supported the use of the measure online, due to a highly significant 
correlation between on-site evaluation and online testing (r = 0.96).    
Social Support  
The Multidimensional Scale of Perceived Social Support (MSPSS; Zimet, Dahlem, 
Zimet & Farley, 1988) is a 12-item measure scored on a scale from 1 (very strongly disagree) 
to 7 (very strongly agree), with a total score range of 12 to 84; the scale contains three 
subscales (four items in each): significant other, family and friends (scores range from 4 to 28 
for each subscale).  Both the total scale and for the individual subscales can be used, with 
higher scores indicating higher levels of social support.  The authors report highly acceptable 
Cronbach’s coefficient alpha co-efficients and good test-retest reliability. The scale is 
relatively short, easy to complete and measures individuals’ levels of social support from 
different sources.  
Stigma 
The Stigma Scale for Chronic Illness (SSCI, Rao et al., 2009) comprises 24 questions 
with two subscales; one scale for felt stigma (labelled self-stigma; 13 questions) and one 
scale for enacted stigma (11 questions).  Each item is scored on a scale of 0 (never) to 4 
(always) with a total score range of 0 – 96 for the full scale, 0 – 52 for the felt scale and 0 – 
44 for the enacted scale.  Higher scores indicate a higher level of stigmatisation.  Internal 
reliability for this scale was assessed by the authors and was found to be highly acceptable. 
The measure was specifically developed for people with chronic neurological illnesses, 
including individuals with MND.  The total score was used alongside the two subscales (felt 
and enacted stigma) for the correlational analyses for this study and the two subscales were 
used in the regression analyses of this study. As part of the validation process, it was 
administered online (Rao et al., 2009).  





The Depression, Anxiety and Stress Scale (DASS-21; Lovibond & Lovibond, 1995) is 
a 21-question scale with three subscales, depression, anxiety and stress (seven questions for 
each subscale).  These are scored on a range of 0 (never) to 3 (almost always) with a total 
range of 0 – 21 for each of the subscales; higher scores indicate a higher level of distress and 
cut-offs have been created to categorise scores as: “normal”, “mild”, “moderate”, “severe” or 
“extremely severe”.  The scale has excellent internal reliability both in its full form and in the 
three subscales (Antony, Bieling, Cox, Enns, Swinson & Haynes, 1998; Henry & Crawford, 
2005).  The measure has been used online in previous research with individuals with MND 
(Lillo, Mioshi, Zoing, Kiernan & Hodges, 2011; Caga, Ramsey, Hogden, Mioshi & Kiernan, 
2015).  
Data Analysis 
 Data analysis was completed using SPSS (Version 26) and Hayes PROCESS macro 
Version 3.4.1.  The sample was checked for missing data prior to any analysis being 
conducted; seven participants had not provided a response to the same question on the SSCI: 
“people with my illness lost their jobs when their employers found out”.  This missing datum 
was replaced with the mean value of this specific subscale of the SSCI (enacted stigma 
subscale) for each person.  No other missing data was identified in the sample.  Outliers were 
identified using boxplots and scores were checked for errors.  Given the relatively small 
sample size, a less conservative method (dividing the skewness or kurtosis value by its 
standard error) was used to assess for skewness and kurtosis (Field, 2005).  Using parameters 
of -3 to +3, the only scale not normally distributed was the MSPSS total score.   
As the MSPSS total score was not normally distributed, non-parametric correlations 
were calculated using Spearman’s correlation coefficients to identify relationships.  




Mediation analyses were then conducted; in each analysis the predictor variable was enacted 
stigma, the mediator variable was felt stigma and the outcome variable was either depression, 
anxiety, or stress.  Each analysis was based on 5000 bootstrap samples to estimate the 
confidence intervals.  Moderation analyses were then conducted to assess the moderating 
effects of social support on the relationship between MND related stress and psychological 
distress.  In each analysis the predictor variable to represent MND related stress was either 
enacted stigma or physical functioning and the outcome variable was either depression, 
anxiety or stress, with social support as the moderating variable. 
 All regressions analyses which contributed to the mediations and moderations were 
checked to ensure that they met assumptions of independent errors, homoscedasticity and 
normalised residuals and that no multicollinearity was present. 
 
Results 
 The mean scores, standard deviations and Cronbach’s alpha scores for each measure 
are reported in Table 2.   
--------------------------------------- 
Insert Table 2 here please 
--------------------------------------- 
 
The mean (SD) score for the SA-ALSFRS-R was 29 (8.62), indicating that levels of 
independent functioning were within the mid-point range.  The majority of scores fell within 
the ‘mild to moderate’ category (43%, n = 33), with ‘moderate to severe’ (30%, n = 23), 
‘advanced disease’ (16%, n = 12) and the ‘minimal to mild’ category (12%, n = 9).   
The mean score for the MSPSS total (M = 66.47; SD = 15.66) indicated that levels of 
social support were towards the higher end of the scale for this sample (possible range: 12-




84). Moreover the mean score for the SSCI total score (M = 32.83; SD = 16.12) indicated that 
levels of stigma were quite low in this sample (possible range: 0 -  96, with higher scores 
indicating higher levels of stigma).   
Regarding the DASS scores, for the depression subscale, the majority of scores were 
in the ‘normal’ category (70%, n = 54), followed by the ‘mild’ (18%, n = 14), and the 
‘moderate’ category (12%, n = 9).  For the anxiety subscale, all the scores fell within the 
‘normal’ category (100%, n = 77).  For the stress subscale, the majority of scores were in the 
‘normal’ category (62%, n = 48), followed by ‘moderate’ (22%, n = 17), ‘mild’ (9%, n = 7), 
‘severe’ (5%, n = 4) and finally the ‘extremely severe’ category (1% n = 1).  This indicates 
that the majority of the sample had non-clinical levels of stress, anxiety and depression.  
Correlations 
 Spearman’s rs correlation coefficients were calculated to determine the relationships 
between the variables; see Table 3.   
 
--------------------------------------- 
Insert Table 3 here please 
    --------------------------------------- 
 
As can be seen in Table 3, none of the demographic or clinical variables correlated 
significantly with the three outcome variables (depression, anxiety or stress).  However, 
statistically significant relationships were found between the two stigma subscales and social 
support variables and all three outcome variables.  Associations were in the predicted 
direction with social support (total score) negatively correlated with depression, anxiety and 
stress and stigma (total score and the two subscales) positively correlated with the three 
outcome measures.  





 As physical functioning significantly correlated with both stigma variables, this was 
initially included in the mediation models as a covariate.  Upon further inspection, this 
variable did not make any significant contribution to the model or impact the findings greatly, 
therefore, this was not included in the final models.  In each analysis the predictor variable 
was enacted stigma, the mediator variable was felt stigma and the outcome variable was 
either depression, anxiety, or stress.  Mediation analyses were conducted to assess the 
mediating effects of felt stigma; see Table 4 and Figures 1 to 3 for the main findings of these 
analyses.   
 
--------------------------------------- 
Insert Table 4 here please 
    --------------------------------------- 
 
--------------------------------------- 








Insert Figure 3 here please 
--------------------------------------- 





Mediation model for depression. 
The total effect of the model was significant (c = .401, 95% CI [.259, .543], p < .001).  
Higher enacted stigma predicted higher felt stigma (a = .941, 95% CI [.683, 1.198], p < .001) 
and higher felt stigma predicted higher depression scores (b = .316, 95% CI [.211, .420], p < 
.001).  A significant indirect effect was found for enacted stigma through felt stigma on 
depression scores (ab = .297, 95% CI [.191, .429]).  The effect size of the completely 
standardised indirect effect was .404.  The direct effect of the model did not remain 
significant when controlling for the effect of the mediational variable of felt stigma (c’ = 
.104, 95% CI [-.049, .257], p > .05). 
Mediation model for anxiety. 
The total effect of the model was significant (c = .196, 95% CI [.080, .312], p < 0.01). 
Higher enacted stigma predicted higher felt stigma (a = .941, 95% CI [.683, 1.198], p < .001) 
and higher felt stigma predicted higher anxiety scores (b = .206, 95% CI [.113, .300], p < 
.001) A significant indirect effect was found for enacted stigma through felt stigma on 
anxiety scores (ab = .1941, 95% CI [.092, .313]).  The effect size of the completely 
standardised indirect effect was .358.  The direct effect of the model did not remain 
significant when controlling for the effect of the mediational variable of felt stigma (c’ = 
.002, 95% CI [-.134, .138], p > .05).  
Mediation model for stress. 
The total effect of the model was significant (c = .365, 95% CI [.242, .488], p < .001).  
Higher enacted stigma predicted higher felt stigma (a = .941, 95% CI [.683, 1.198], p < .001) 
and higher felt stigma predicted higher stress scores (b = .193, 95% CI [.092, .294], p < .001).  
A significant indirect effect was found for enacted stigma through felt stigma on stress scores 
(ab = .182, 95% CI [.069, .278]).  The effect size of the completely standardised indirect 




effect was .281.  The direct effect of the model remained significant when controlling for the 
effect of the mediational variable of felt stigma (c’ = .184, 95% CI [.036, .332], p < .05).    
Moderation Analysis 
 To assess the moderating effects of social support on the relationship between MND 
related stress and psychological distress, moderation analyses were conducted.   In each 
analysis the predictor variable to represent MND related stress was either enacted stigma or 
physical functioning and the outcome variable was either depression, anxiety, or stress with 
social support as the moderating variable.  There was no significant moderation effect of 
social support found in any of the models.  For MND related stress, conceptualised as either 
enacted stigma or physical functioning, neither of the models including stress were 
significant (p = .179 for enacted stigma; p = .237 for physical functioning), neither of the 
models including anxiety were significant (p  = .789; p = .816 respectively) and nor were 
those models including depression (p = .164; p = .379 respectively).   
Discussion 
The present study investigated the impact of social support and perceived stigma on 
the relationship between MND related stress and psychological distress in individuals with 
MND.  Statistically significant correlations were found between social support, stigma (total 
score, self (felt) subscale and enacted subscale) and all the outcome variables in the predicted 
directions. The correlational findings suggest that individuals with higher levels of social 
support had lower levels of psychological distress (depression, anxiety and stress) and that 
individuals with higher levels of stigma (both felt and enacted) also experienced higher levels 
of psychological distress. 
To explore these relationships further, mediation and moderation analyses were 
conducted.  In relation to the role of felt stigma in mediating the relationship between MND 
related stress (enacted stigma) and psychological distress (depression, anxiety and stress), 




analyses yielded significant results. The effect of felt stigma as a mediator of the relationship 
between enacted stigma and psychological distress was significant.  Each of the mediation 
models found a significant indirect effect via this mediator. This suggests that the relationship 
between enacted stigma and psychological distress is mediated by the individual’s levels of 
felt stigma.  These findings are consistent with the theoretical model of self stigma proposed 
by Corrigan and colleagues (Corrigan & Watson, 2002; Corrigan, Watson & Barr, 2006) 
whereby public attitudes (enacted stigma) produce personal responses and self stigmatisation 
which then leads to negative consequences for the individual.   
This process begins when an individual with a condition that induces stigmatisation 
experiences discrimination (enacted stigma) which makes them aware of the negative 
stereotypes attached to their condition.  This awareness of the negative stereotype is 
conceptualised as felt (perceived) stigma and the actual experience of discrimination (e.g. 
social exclusion) is conceptualised as enacted stigma.  The process can lead to the individual 
agreeing with the negative stereotypes and then internalising the stereotype.  This 
internalisation is conceptualised as self stigma, which then results in consequences for the 
self (such as psychological distress).  The results of the present study lend support to this 
model as it identified a significant indirect effect of felt stigma on the relationship between 
enacted stigma and depression, anxiety and stress.  However, the direct path between enacted 
stigma and stress also remained significant after mediation analysis, suggesting that the actual 
experience of discrimination also relates to stress levels for individuals with MND 
independent of the process of internalisation of the negative stereotype.  It is interesting to 
note that theoretical accounts of the effects of disablism from other disciplines, such as the 
social model of disability (Thomas, 2007) and the later concept of psycho-emotional 
disablism (see Simpson & Thomas, 2014), would also predict a direct route from hostile 
disablist attitudes to well-being and an indirect one via the internalisation of these attitudes. 




Moderation analyses revealed no significant effect for the role of social support as a 
moderator on the relationship between MND related stress (enacted stigma or physical 
functioning) and psychological distress (depression, anxiety and stress). 
 Limitations  
While this study has used established procedures to measure mediation, it is still 
acknowledged that this approach is limited in confirming causal inferences (Levin, 2006).   
Sample size is a further limitation in this study, as only a relatively small sample size was 
achieved. The suggested sample size to achieve a medium effect for the moderation analysis 
was 472 participants, and this study only recruited 77 participants, falling well below the 
suggested requirement.   Due to the relative rarity of the condition, with prevalence rates for 
North America and Europe of around two per 100,000 of the population (Worms, 2001), and 
its rapid degenerative effect, recruiting enough participants to achieve a sample size to test 
moderation was challenging. While an online survey method was used to extend recruitment 
internationally, this did rely on the cooperation of organisations and support services.  For 
example, only one local organisation in the US shared this information, resulting in only a 
small proportion (3%) of participants from this country.   
Levels of stigma were quite low in this sample and most of the sample had ‘normal’ 
levels of stress, anxiety and depression.  A review of psychosocial aspects of MND (McLeod 
& Clarke, 2007) identified varying levels of depression and anxiety within MND populations; 
these ranged from 0% to 50% for depression (defined as moderate to severe) and 11% to 26% 
for anxiety.  Therefore, given the relatively high variability, it is unclear whether the current 
sample may be considered representative although the present findings may not be applicable 
to samples with higher levels of stigma and psychological distress.  Furthermore, participants 
in this study were mainly longer surviving individuals, which again might limit 




generalisability, with the very low levels of depression, anxiety and stress not similar in more 
recently diagnosed individuals.  
Finally, this study had a very highly selected sample as, despite at least 16 counties 
included, only a small number from each country answered the questionnaire.  Given the 
online format, this also restricted or privileged those individuals interested in this topic and 
who had access to an online platform.  
 Clinical Implications 
 The findings from this study provide implications for clinical practice. In particular, 
results suggest that if psychological distress is identified in an individual with MND, then it 
may be beneficial to use both social and psychological factors to inform formulations and be 
aware of the potential of both routes to impact when considering a comprehensive 
intervention plan.  
Interventions aimed at targeting stigma often operate on several levels: intrapersonal, 
interpersonal, organisational/ institutional, community and governmental/ structural 
(Heijnders & Van Der Meij, 2006).  Systematic reviews have identified that the most 
effective interventions are aimed at the intrapersonal, interpersonal and community levels 
(Heijnders & Van Der Meij, 2006; Rao et al., 2019).  Effective intervention strategies for 
reducing stigma for conditions such as HIV, mental health diagnoses and leprosy include 
education (e.g., Ngoc, Weiss & Trung, 2016), counselling (e.g., Lusli et al., 2016) , cognitive 
behavioural therapy (Corrigan & Calabrese, 2005), social marketing (Henderson et al., 2012), 
drama therapy (Orkibi, Bar & Eliakim, 2014) and social support groups (Thurman, Jarabi & 
Rice, 2012), and combinations of these (e.g., Uys et al., 2009). Moreover, research suggests 
that mindfulness is positively associated with stigma resistance in individuals with a 
psychiatric diagnosis (Chan, Lee & Mak, 2018) suggesting that mindfulness-based 
interventions may be beneficial in bolstering the self against the effects of enacted stigma. 




Mindfulness-based interventions have also been identified as effective in reducing 
psychological distress for individuals with a diagnosis of MND (Pagnini et al., 2015; Pagnini 
et al., 2017) which could make them useful for a number of adaptive purposes.  
However, individually focused interventions are clearly not sufficient on their own to 
tackle stigma and, for example, using the concept of psycho-emotional disablism (Thomas, 
2007), it is also important to look at addressing the limitations and barriers society imposes 
on individuals with impairments. Socially engaged activism, while not the usual intervention 
route for health and clinical psychologists (Simpson & Thomas, 2014), is important in 
effecting societal change to highlight and break down these structural barriers.  
Conclusion 
 Mediation analyses identified significant findings for the indirect effect of felt stigma 
on the relationship between MND related enacted stigma and psychological distress 
(depression, anxiety and stress), while a direct route from enacted stigma to psychological 
distress also remained in the case of stress (one of the three relationships examined).  
Moderation analysis revealed no significant role for social support as a moderator of the 
relationship between MND related stress and psychological distress.  These findings should 
be used to improve interventions for individuals with a diagnosis of MND as they highlight 
the importance of considering both social and psychological factors when psychological 
distress has been identified.  For individuals with MND, the roots and causes of 
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Table 1: Demographic information of participants (N= 77) 
Characteristic N % 
Male 43 55.8 
Female 34 44.2 
Nationality    
Australian 8 5.8 
British/English/Welsh/Northern Irish 18 23.4 
Canadian 14 18.2 
Dutch 1 0.7 
German 1 0.7 
Indian 1 0.7 
Irish 3 2.2 
New Zealander 18 23.4 
NZ European 3 2.2 
South African 4 2.9 
Swedish 1 0.7 
USA 2 1.4 
USA Canadian 1 0.7 
Unknown 2 1.4 
Relationship status    
Single 3 2.2 
Cohabiting/married/civil partnership 58 71.4 
Divorced 9 6.5 
Widowed 4 2.9 




Other 3 2.2 
Carer assistance required to complete survey   
Yes 7 9.1 
No  70 90.9 
Note. Participants were on average 59.1 years old (SD = 10.6; range = 36 - 83).  Participants 
had an average time since symptom onset of 4.8 years (SD = 4.4; median = 3.5; range = 0.6 – 
22).  Participants had an average time since diagnosis of 3.5 years (SD = 3.9; range = 0.1 – 
21). 
  
   
 
 
Table 2: Descriptive statistics for all study measures 
Variable Mean Standard Deviation Cronbach’s alpha 
DASS-21 Stress 7.03 4.59 .86 
DASS-21 Anxiety 5.32 3.85 .75 
DASS-21 Depression 7.19 5.22 .91 
SA-ALSFRS-R 29.00 8.62 .82 
MSPSS Total 66.47 15.66 .94 
MSPSS Significant Other 24.10 5.68 .94 
MSPSS Family 22.16 6.16 .90 
MSPSS Friends 20.21 6.27 .91 
SSCI Total 32.83 16.12 .92 
SSCI Self-Subscale 22.48 10.36 .90 
SSCI Enacted-Subscale 10.09 7.09 .87 
Note: DASS-21 = Depression, Anxiety and Stress Scale (measuring psychological distress); SA-
ALSFRS-R = Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale Revised 
(measuring physical functioning); MSPSS = Multidimensional Scale of Perceived Social Support 
(measuring social support); SSCI = Stigma Scale for Chronic Illness (measuring stigma); SSCI Self-




   
 
 
Table 3: Correlation matrix of Spearman’s correlation coefficients  
 
Variable 1 2 3 4 5 6 7 8 9 10 
1. Age 1.000 .090 -.031 .198 -.134 -.140 -.179 -.175 -.026 -.052 
2. Gender  1.000 -.165 -.097 .028 .014 -.016 .114 -.067 -.070 
3. SA-ALSFRS-R   1.000 .255* -.402** -.395** -.232* -.153 -.209 -.180 
4. MSPSS Total    1.000 -.483** -.483** -.433** -.385** -.399** -.437** 
5. SSCI Total     1.000 .929** .801** .538** .447** .660** 
6. SSCI Self      1.000 .586** .525** .526** .689** 
7. SSCI Enacted       1.000 .440** .244* .465** 
8. DASS-21 Stress        1.000 .627** .787** 
9. DASS-21 Anxiety         1.000 .588** 
10. DASS-21 Depression          1.000 
* p < 0.05; ** p < 0.01 





















Depression Model     
Enacted Stigma → Felt Stigma (IV to mediator, path a) .941*** .129 [.683, 1.198]  
Felt Stigma → Depression (mediator to DV, path b) .316*** .053 [.211, .420]  
Enacted Stigma → Depression (total effect, path c) .401*** .071 [.259, .543]  
Enacted Stigma → Depression (direct effect, path c’) .104 .077 [-.049, .257]  
Enacted Stigma → Depression (indiect effect, path a x b) .297⸸ .061 [.191 - .429] .404 
Anxiety Model     
Enacted Stigma → Felt Stigma (IV to mediator, path a)  .941*** .129 [.683, 1.198]  
Felt Stigma → Anxiety (mediator to DV, path b) .206*** .047 [.113, .300]  
Enacted Stigma → Anxiety (total effect, path c) .196** .058 [.080, .312]  




Enacted Stigma → Anxiety (direct effect, path c’) .002 .068 [-.134, .138]  
Enacted Stigma → Anxiety (indiect effect, path a x b) .194⸸ .056 [.092 - .313] .358 
Stress Model     
Enacted Stigma → Felt Stigma (IV to mediator, path a) .941*** .129 [.683, 1.198]  
Felt Stigma → Stress (mediator to DV, path b) .193*** .051 [.092, .294]  
Enacted Stigma → Stress (total effect, path c) .365*** .062 [.242, .488]  
Enacted Stigma → Stress (direct effect, path c’) .184* .074 [.036, .332]  
Enacted Stigma → Stress (indirect effect, path a x b) .182⸸ .052 [.069 - .278] .281 
* p < 0.05; ** p < 0.01; *** p < 0.001 
 
Note: ⸸ - due to the way that the indirect effect is calculated, only a confidence interval, but not a p- value, is available.  




Figure 1: Regression coefficients for the relationship between enacted stigma and depression 
as mediated by felt stigma.  Standardized coefficients are included in parentheses. 
 

















Figure 2: Regression coefficients for the relationship between enacted stigma and anxiety as 
mediated by felt stigma.  Standardized coefficients are included in parentheses.. 
 



















Figure 3: Regression coefficients for the relationship between enacted stigma and stress as 
mediated by felt stigma.  Standardized coefficients are included in parentheses. 
 
*** p < 0.001 
*  p < 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
